Exclusive: Ozempic Prescription Startup Shake-Up Hits Management
A significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
Choosing the best Dividend Aristocrats Etf for retirees involves yield, cost, and risk assessment. This intro guides the evaluation process.
22,751 articlesA significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
When a hedge fund disclosed a sizable new stake in Asbury Automotive, the market reacted. This guide breaks down why ...
Bitcoin price just lost momentum after a hotter-than-expected US PPI. Traders weigh how sticky inflation could delay ...
Linkhome is accelerating its AI-driven lending ambitions by acquiring Mortgage One Group. The deal, slated to close b...
Insider trading patterns at Palantir raise questions about the stock's growth path as defense sector stocks attract c...
Applied Materials is set to report Q2 results after the close, as investors weigh demand signals for AI chips and adv...
A Two Harbors shareholder files a federal lawsuit to block the CCM merger vote, alleging deceptive proxy disclosures ...
U.S. stocks wobbled Friday as the Russell 2000 slipped, but the small-cap rally remains a defining thread of 2026. In...
The WHO has declared the latest ebola outbreak a public health emergency of international concern, prompting a wave o...
Standard Chartered is moving to absorb Zodia Custody's crypto operations, extending its digital-asset platform. The d...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...